These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 23054653)

  • 1. Two cases of pediatric essential thrombocythemia managed effectively with hydroxyurea.
    Dua V; Yadav SP; Kumar V; Saxena R; Sachdeva A
    Int J Hematol; 2012 Dec; 96(6):810-3. PubMed ID: 23054653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contemporary management of essential thrombocythemia in children.
    Randi ML; Bertozzi I; Putti MC
    Expert Rev Hematol; 2019 May; 12(5):367-373. PubMed ID: 30925843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polycythemia vera and essential thrombocythemia: 2015 update on diagnosis, risk-stratification and management.
    Tefferi A; Barbui T
    Am J Hematol; 2015 Feb; 90(2):162-73. PubMed ID: 25611051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombocytosis in rheumatoid arthritis: JAK2V617F-positive essential thrombocythemia.
    Ayvaz OC; Yavasoglu I; Kadikoylu G; Bozkurt G; Bolaman Z
    Rheumatol Int; 2012 Jan; 32(1):269-71. PubMed ID: 21243496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. JAK2V617F mutation and hydroxyurea treatment as determinants of immature platelet parameters in essential thrombocythemia and polycythemia vera patients.
    Panova-Noeva M; Marchetti M; Buoro S; Russo L; Leuzzi A; Finazzi G; Rambaldi A; Ottomano C; Ten Cate H; Falanga A
    Blood; 2011 Sep; 118(9):2599-601. PubMed ID: 21750318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and histological characteristics of livedo racemosa in essential thrombocythemia: A report of two cases and review of the published works.
    Inoue S; Okiyama N; Okune M; Shiraki N; Kessoku R; Fujimoto M
    J Dermatol; 2017 Jan; 44(1):84-87. PubMed ID: 27570091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. JAK2V617F mutation-positive childhood essential thrombocythemia associated with cerebral venous sinus thrombosis.
    Kurosawa H; Okuya M; Matsushita T; Kubota T; Endoh K; Kuwashima S; Hagisawa S; Sato Y; Fukushima K; Sugita K; Okada Y; Park MJ; Hayashi Y; Arisaka O
    J Pediatr Hematol Oncol; 2009 Sep; 31(9):678-80. PubMed ID: 19707158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Essential differences in clinical and bone marrow features in BCR/ABL-positive thrombocythemia compared to thrombocythemia in the BCR/ABL-negative myeloproliferative neoplasms essential thrombocythemia and polycythemia vera.
    Michiels JJ; Pich A; De Raeve H; Gadisseur A
    Acta Haematol; 2015; 133(1):52-5. PubMed ID: 25116159
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of essential thrombocythemia].
    Alvarez-Larrán A; Cervantes F; Besses C
    Med Clin (Barc); 2013 Sep; 141(6):260-4. PubMed ID: 23490491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of coated-platelet levels in patients with essential thrombocythemia with and without hydroxyurea treatment.
    Reményi G; Szász R; Debreceni IB; Szarvas M; Batár P; Nagy B; Kappelmayer J; Udvardy M
    Platelets; 2013; 24(6):486-92. PubMed ID: 23216455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polycythemia vera and essential thrombocythemia: 2012 update on diagnosis, risk stratification, and management.
    Tefferi A
    Am J Hematol; 2012 Mar; 87(3):285-93. PubMed ID: 22331582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct evidence for normalization of platelet function resulting from platelet count reduction in essential thrombocythemia.
    Tsantes AE; Nikolopoulos GK; Tsirigotis P; Zoi K; Zomas A; Kapsimali V; Kopterides P; Chondropoulos S; Dervenoulas J; Mantzios G
    Blood Coagul Fibrinolysis; 2011 Sep; 22(6):457-62. PubMed ID: 21836466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polycythemia vera and essential thrombocythemia: 2019 update on diagnosis, risk-stratification and management.
    Tefferi A; Barbui T
    Am J Hematol; 2019 Jan; 94(1):133-143. PubMed ID: 30281843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Essential thrombocythemia: scientific advances and current practice.
    Tefferi A
    Curr Opin Hematol; 2006 Mar; 13(2):93-8. PubMed ID: 16456375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysplasia of all granulocyte lineages in myelodysplastic evolution of essential thrombocythemia.
    Bain BJ; Garnett C; Deplano S; Naresh K; Kanfer E
    Am J Hematol; 2013 May; 88(5):426. PubMed ID: 23460316
    [No Abstract]   [Full Text] [Related]  

  • 16. An unusual cause of cerebellar hemorrhage in a young patient: essential thrombocythemia.
    Adam R; Priglinger M; Harrington T; Gottlieb D; Krause M
    J Stroke Cerebrovasc Dis; 2014; 23(5):e373-4. PubMed ID: 24582788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Essential thrombocythemia in a child with elevated thrombopoietin concentrations and skeletal anomalies.
    Robins EB; Niazi M
    Pediatr Blood Cancer; 2008 Apr; 50(4):859-61. PubMed ID: 17455310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A preschool child with primary thrombocytosis].
    Ling C; Zhu GH; Jin L
    Zhonghua Er Ke Za Zhi; 2013 Jul; 51(7):541-2. PubMed ID: 24267139
    [No Abstract]   [Full Text] [Related]  

  • 19. Essential thrombocythemia in a child: diagnostic and therapeutic dilemma.
    Asghar R; Behzad E; Mohammad GA
    Saudi Med J; 2005 Nov; 26(11):1806-8. PubMed ID: 16311671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxycarbamide Plus Aspirin Versus Aspirin Alone in Patients With Essential Thrombocythemia Age 40 to 59 Years Without High-Risk Features.
    Godfrey AL; Campbell PJ; MacLean C; Buck G; Cook J; Temple J; Wilkins BS; Wheatley K; Nangalia J; Grinfeld J; McMullin MF; Forsyth C; Kiladjian JJ; Green AR; Harrison CN; ; ; ;
    J Clin Oncol; 2018 Dec; 36(34):3361-3369. PubMed ID: 30153096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.